{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-000381","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2023-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.715760+00:00","generated_at":"2026-06-20T19:28:58.564884+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ChromaDex names Brianna Gerber CFO effective Jan 1, 2023; salary $325K","bullets":["Brianna Gerber appointed CFO after serving as interim CFO since August 2022.","Base salary $325,000; discretionary target bonus 50% of base; LTI opportunity 70% of base (Black-Scholes).","Termination w/o cause/good reason: 12-mo salary continuation, pro-rata bonus, COBRA (12 mos), accelerated vesting.","CEO Fried highlights her role in shepherding ChromaDex to EBITDA positive business with fiscal responsibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-000381","json":"https://secwatch.observer/filing/0001628280-23-000381.json","markdown":"https://secwatch.observer/filing/0001628280-23-000381.md","text":"https://secwatch.observer/filing/0001628280-23-000381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023000381/0001628280-23-000381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023000381/cdxc-20230103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T19:28:58.564884+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"813fffdbc4","claim":"Brianna Gerber was appointed as Chief Financial Officer at Niagen Bioscience, Inc..","evidence_excerpt":"appointed Brianna Gerber as Chief Financial Officer of the Company, effective as of January 1, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023000381/0001628280-23-000381-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}